Financial Data and Key Metrics Changes - The company reported Q4 revenue of $38.5 million, reflecting a 32% year-over-year increase, and full-year revenue of $145.9 million, representing a 40% year-over-year growth [11][28] - Annual recurring revenue (ARR) at the end of 2025 was $120.5 million, showing a 21% year-over-year growth [11][29] - Adjusted EBITDA for 2025 was $11.1 million, compared to a loss of $21 million in 2024, marking a $32 million improvement [12][29] - Total cash equivalents and marketable securities increased by $12.8 million sequentially in Q4 to $69 million, indicating strong cash collection efforts [12][30] Business Line Data and Key Metrics Changes - The company welcomed over 60 new customers in Q4, bringing the total to over 1,200 customers globally [13] - The fourth quarter saw a 13% year-over-year increase in remaining performance obligation (RPO) to $293.4 million [13][29] - The company added 12 new school districts and 3 universities in Q4, contributing to a total of approximately 300 million students and visitors screened [15][16] Market Data and Key Metrics Changes - The company expanded its presence in the healthcare sector, screening over 1 million patients, healthcare workers, and visitors daily across medical facilities [16] - In the sports and live entertainment market, the company added 65 new customers in 2025, screening nearly 1.5 million visitors daily [18] - The workplace segment saw multiple new Fortune 500 customers, highlighting the growing demand for security solutions in high-traffic environments [20] Company Strategy and Development Direction - The company aims to build a scalable, high-growth hardware-enabled subscription business, focusing on modern technology-enabled security solutions [7][23] - The strategy includes investing in product innovation and expanding the installed base while maintaining a disciplined approach to market expansion [23][35] - The company anticipates that weapon screening will become standard infrastructure in certain buildings, similar to sprinkler systems [23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the continued demand for security solutions due to escalating threat levels across various public venues [7] - The company raised its 2026 revenue guidance to $172 million-$178 million, reflecting strong momentum and a healthy pipeline [22][31] - Management expects ARR growth to outpace revenue growth in 2026, with adjusted EBITDA margins expanding into the high single digits [22][35] Other Important Information - The company will host its 2026 Investor Day on June 9, 2026, to provide updates on strategy and product innovation [5][6] - The company has made significant changes to its pricing model and fulfillment strategy, which are expected to enhance long-term revenue capture [22][31] Q&A Session Summary Question: Context for raised revenue guidance and ARR growth - Management anticipates ARR to accelerate throughout the year due to changes in pricing and fulfillment strategies [40][42] Question: Overall gross margin trends - Management expects gross margins to improve in 2026 compared to 2025, driven by increased gross profit dollars from RPO [43][44] Question: Linkage between cash flow and adjusted EBITDA forecast - Management expects to be cash flow positive in the second half of 2026, with improved cash flow trajectory anticipated [49][50] Question: Mix between new and existing customers - The company reported a roughly 50/50 split between new customer acquisitions and existing customer expansions [55][67] Question: Impact of AHA certification on hospital deals - Management believes the partnership with the American Hospital Association will accelerate hospital deals, especially with regulatory changes mandating weapon screening [68]

Evolv Technologies (NasdaqCM:EVLV) Q4 2025 Earnings call March 10, 2026 04:30 PM ET Company ParticipantsAlex Latimore - Research AssociateBrian Norris - SVP of Finance and Investor RelationsChris Kutsor - CFOJohn Kedzierski - President and CEOShaul Eyal - Managing Director in Equity ResearchConference Call ParticipantsEric Martinuzzi - Senior Research AnalystJeremy Hamblin - Senior Research AnalystOperatorGood afternoon, and welcome to the Evolv Technology Fourth Quarter Earnings Results Conference Call. Al ...

Financial Data and Key Metrics Changes - The company reported Q4 revenue of $38.5 million, reflecting a 32% year-over-year increase, and full-year revenue of $145.9 million, representing a 40% year-over-year growth [11][26] - Annual recurring revenue (ARR) at the end of 2025 was $120.5 million, showing a 21% year-over-year growth [11][30] - Adjusted EBITDA for 2025 was $11.1 million, compared to a loss of $21 million in 2024, marking a $32 million improvement [12][30] - Total cash equivalents and marketable securities increased by $12.8 million sequentially in Q4 to $69 million, indicating strong cash collection efforts [12][31] Business Line Data and Key Metrics Changes - The company added over 60 new customers in Q4, bringing the total to over 1,200 customers globally [13][56] - The fourth quarter saw a 13% year-over-year increase in remaining performance obligation (RPO), reaching $293.4 million [13][30] - The company reported strong demand for its Gen Two Express platform, with existing customers upgrading [13][30] Market Data and Key Metrics Changes - The company continues to expand in the education sector, adding 12 new school districts and 3 universities in Q4, screening approximately 300 million students and visitors throughout the year [16][17] - In healthcare, the company is now screening over 1 million patients, healthcare workers, and visitors daily across medical facilities [17] - The sports and live entertainment market saw the addition of 65 new customers in 2025, with nearly 1.5 million visitors screened daily [19][20] Company Strategy and Development Direction - The company aims to build a scalable, high-growth hardware-enabled subscription business, focusing on modern technology-enabled security solutions [6][7] - The strategy includes investing in product innovation and expanding the customer base while maintaining a disciplined approach to working capital management [24][25] - The company anticipates that weapon screening will become standard infrastructure in certain buildings, similar to sprinkler systems [25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the continued demand for security solutions due to escalating threat levels in public venues and workplaces [6][7] - The company raised its revenue guidance for 2026 to a range of $172 million to $178 million, expecting ARR growth of 20% to 25% [24][32] - Management highlighted the importance of innovation in weapon detection accuracy and cost as key to maintaining a competitive edge [25] Other Important Information - The company will host its 2026 Investor Day on June 9, 2026, to provide updates on strategy and product innovation [5] - The company is transitioning to a direct fulfillment model for purchase subscriptions, which is expected to enhance revenue and gross profit over time [26][30] Q&A Session Summary Question: Context for raised revenue guidance despite modest sequential ARR growth - Management anticipates ARR to accelerate throughout the year due to changes in pricing and fulfillment models [41][43] Question: Overall adjusted gross margins trend for 2026 - Management expects gross margins to be in line or slightly better in 2026 compared to 2025, with more gross profit dollars being pushed into RPO [44][45] Question: Timing for production from Plexus relationship - Management confirmed that full ramp with Plexus is expected in the second half of 2026, which will provide a tailwind to gross margins [46][47] Question: Mix between new logos and existing customers - Management indicated a consistent 50/50 split between new customer acquisitions and existing customer expansions [55][69] Question: Impact of AHA certification on hospital deals - Management expressed optimism that the AHA partnership will accelerate hospital deals, especially with regulatory changes mandating weapon screening [70]